Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07826546) titled 'Is Central Sensitization a Prognostic Indicator in Chronic Nonspecific Low Back Pain?' on Sept. 12.
Study Type: Observational
Primary Sponsor: Mardin Artuklu University
Condition:
Chronic Nonspecific Low Back Pain
Recruitment Status: Recruiting
Date of First Enrollment: June 1, 2026
Target Sample Size: 180
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07826546
Disclaimer: Curated by HT Syndication....